RxSight (RXST) Stock: Buy, Sell, or Hold?
RXST - RxSight, Inc. Common Stock
$6.02
0.06 (1.01%)
â˛
5d:
-7.95%
30d:
-14.73%
90d:
+25.42%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When RXST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: RXST is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: RXST is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: RXST is currently trading at $6.02, which is considered slightly low relative to its 30-day fair value range of $6.20 to $6.90.
Technical Outlook: Technically, RXST is showing sideways momentum. Immediate support is located at $5.78, while resistance sits at $7.44.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $7.79 (+29.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RXST is showing sideways momentum. Immediate support is located at $5.78, while resistance sits at $7.44.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $7.79 (+29.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$6.20 -
$6.90
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 29.4% below Wall St target ($7.79)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$6.20 -
$6.90
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$5.78
Resistance Level
$7.44
Current Trend
Sideways
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.64
Wall Street Target
$7.79
(+29.4%)
Revenue Growth (YoY)
0.3%
Profit Margin
-36.8%
Share & Embed Analysis
Last updated: September 12, 2026 2:34 AM ET
Data refreshes hourly during market hours. Next update: 3:34 AM
Data refreshes hourly during market hours. Next update: 3:34 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RXST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
